Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity

Simple item page
dc.citation.firstpage6217en_US
dc.citation.journalTitleBiomaterials Scienceen_US
dc.citation.lastpage6229en_US
dc.citation.volumeNumber10en_US
dc.contributor.authorPogostin, Brett H.en_US
dc.contributor.authorYu, Marina H.en_US
dc.contributor.authorAzares, Alon R.en_US
dc.contributor.authorEuliano, Erin M.en_US
dc.contributor.authorLai, Cheuk Sun Edwinen_US
dc.contributor.authorSaenz, Gabrielen_US
dc.contributor.authorWu, Samuel X.en_US
dc.contributor.authorFarsheed, Adam C.en_US
dc.contributor.authorMelhorn, Sarah M.en_US
dc.contributor.authorGraf, Tyler P.en_US
dc.contributor.authorWoodside, Darren G.en_US
dc.contributor.authorHartgerink, Jeffrey D.en_US
dc.contributor.authorMcHugh, Kevin J.en_US
dc.date.accessioned2022-11-03T14:38:40Zen_US
dc.date.available2022-11-03T14:38:40Zen_US
dc.date.issued2022en_US
dc.description.abstractAdjuvants play a critical role in enhancing vaccine efficacy; however, there is a need to develop new immunomodulatory compounds to address emerging pathogens and to expand the use of immunotherapies. Multidomain peptides (MDPs) are materials composed of canonical amino acids that form injectable supramolecular hydrogels under physiological salt and pH conditions. MDP hydrogels are rapidly infiltrated by immune cells in vivo and have previously been shown to influence cytokine production. Therefore, we hypothesized that these immunostimulatory characteristics would allow MDPs to function as vaccine adjuvants. Herein, we demonstrate that loading antigen into MDP hydrogels does not interfere with their rheological properties and that positively charged MDPs can act as antigen depots, as demonstrated by their ability to release ovalbumin (OVA) over a period of 7–9 days in vivo. Mice vaccinated with MDP-adjuvanted antigen generated significantly higher IgG titers than mice treated with the unadjuvanted control, suggesting that these hydrogels potentiate humoral immunity. Interestingly, MDP hydrogels did not elicit a robust cellular immune response, as indicated by the lower production of IgG2c and smaller populations of tetramer-positive CD8+ T splenocytes compared to mice vaccinated alum-adjuvanted OVA. Together, the data suggest that MDP hydrogel adjuvants strongly bias the immune response towards humoral immunity while evoking a very limited cellular immune response. As a result, MDPs may have the potential to serve as adjuvants for applications that benefit exclusively from humoral immunity.en_US
dc.identifier.citationPogostin, Brett H., Yu, Marina H., Azares, Alon R., et al.. "Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity." <i>Biomaterials Science,</i> 10, (2022) Royal Society of Chemistry: 6217-6229. https://doi.org/10.1039/D2BM01242A.en_US
dc.identifier.doihttps://doi.org/10.1039/D2BM01242Aen_US
dc.identifier.urihttps://hdl.handle.net/1911/113799en_US
dc.language.isoengen_US
dc.publisherRoyal Society of Chemistryen_US
dc.rightsThis is an author's peer-reviewed final manuscript, as accepted by the publisher. The published article is copyrighted by the Royal Society of Chemistry.en_US
dc.titleMultidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunityen_US
dc.typeJournal articleen_US
dc.type.dcmiTexten_US
dc.type.publicationpost-printen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Pogostin-et-al-2022.pdf
Size:
24.65 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Faculty Publications
Bioengineering Publications
Chemistry Publications